Top Gynecology & Infertility Medicines Company in India - Adorefem

  Over the years, infertility has become a prevailing concern among many couples, which has directly impacted the overall market of this segment. In India alone, this market is expected to hold a value of approximately US$1,136.8 million by 2030, meaning it is growing at a CAGR of 7%. When digging deeper, it has been seen that these figures continue to rise globally as well.  Therefore, many pharma professionals are jumping into this domain to kickstart their careers in an impactful direction. If you are looking to sustain for a longer time along with financial gains, then a reliable IVF medicine supplier in India like Adorefem can be of great help. Not only their experience, but also their working standards showcase how good their brand position is and will help you to attain a long-term stable position in this booming segment.  Current Market Statistics of the Infertility Drug Market in India  As discussed earlier, it has been clear that investing in female care m...

  The healthcare field in India developed assisted reproductive technology from its initial status as a specialized medical service into a major healthcare sector within the last ten years. The need for assisted reproductive services has grown. This is because of increased infertility rates and people starting families at a later time. The rising frequency of hormonal disorders and changes in daily life patterns are also the blame factors. B2B expansion in this market sector depends mainly on the growth of injectable fertility medications. With a reliable gynecology medicine supplier in India , you can grow significantly.  The Rising Need for Assisted Reproductive Treatments IVF medications have become more accessible to people in India because they have received wider social acceptance throughout urban and semi-urban areas. Couples are actively seeking medical solutions, and fertility clinics are expanding their services to areas beyond metropolitan centers. The procedures de...